JohnPRileyMD

PubMed

• Adoptive transfer of autologous natural killer cells leads to high levels of circulating natural killer cells but does not mediate tumor regression.
  Parkhurst, M.R., Riley, J.P., Dudley, M.E., Rosenberg, S.A.> ;Clin Cancer Res. 2011 Oct 1
• A TCR targeting the HLA-A*0201-restricted epitope of MAGE-A3 recognizes multiple epitopes of the MAGE-A antigen superfamily in several types of cancer.
  Chinnasamy, N., Wargo, J.A., Yu, Z., Rao, M., Frankel, T.L., Riley, J.P., Hong, J.J., Parkhurst, M.R., Feldman, S.A., Schrump, D.S., Restifo, N.P., Robbins, P.F., Rose...> ;J Immunol. 2011 Jan 15
• A novel method for isolation of human lung T cells from lung resection tissue reveals increased expression of GAPDH and CXCR6.
  Day CE, Zhang SD, Riley J, Gant T, Wardlaw AJ, Guillen C> ;J. Immunol. Methods. 2009-03-15
• Characterization of genetically modified T-cell receptors that recognize the CEA:691-699 peptide in the context of HLA-A2.1 on human colorectal cancer cells.
  Parkhurst, M.R., Joo, J., Riley, J.P., Yu, Z., Li, Y., Robbins, P.F., Rosenberg, S.A.> ;Clin Cancer Res. 2009-01-01
• Extrathymic generation of tumor-specific T cells from genetically engineered human hematopoietic stem cells via Notch signaling.
  Zhao, Y., Parkhurst, M.R., Zheng, Z., Cohen, C.J., Riley, J.P., Gattinoni, L., Restifo, N.P., Rosenberg, S.A., Morgan, R.A.> ;Cancer Res. 2007 Mar 15
• Comparison of common gamma-chain cytokines, interleukin-2, interleukin-7, and interleukin-15 for the in vitro generation of human tumor-reactive T lymphocytes for adop...
  Liu S, Riley J, Rosenberg S, Parkhurst M> ;J. Immunother.. 2006-01-01
• Presentation of tumor antigens by dendritic cells genetically modified with viral and nonviral vectors.
  Lotem M, Zhao Y, Riley J, Hwu P, Morgan RA, Rosenberg SA, Parkhurst MR> ;J. Immunother.. 2006-01-01
• Immunization of patients with the hTERT:540-548 peptide induces peptide-reactive T lymphocytes that do not recognize tumors endogenously expressing telomerase.
  Parkhurst, M.R., Riley, J.P., Igarashi, T., Li, Y., Robbins, P.F., Rosenberg, S.A.> ;Clin Cancer Res. 2004 Jul 15
• Induction of CD4+ Th1 lymphocytes that recognize known and novel class II MHC restricted epitopes from the melanoma antigen gp100 by stimulation with recombinant protein.
  Parkhurst, M.R., Riley, J.P., Robbins, P.F., Rosenberg, S.A.> ;J Immunother. 2004-03-01
• Hybrids of dendritic cells and tumor cells generated by electrofusion simultaneously present immunodominant epitopes from multiple human tumor-associated antigens in t...
  Parkhurst, M.R., DePan, C., Riley, J.P., Rosenberg, S.A., Shu, S.> ;J Immunol. 2003 May 15
• Identification of BING-4 cancer antigen translated from an alternative open reading frame of a gene in the extended MHC class II region using lymphocytes from a patien...
  Rosenberg, S.A., Tong-On, P., Li, Y., Riley, J.P., El-Gamil, M., Parkhurst, M.R., Robbins, P.F.> ;J Immunol. 2002 Mar 1
• Identification of a New Shared HLA-A2.1 Restricted Epitope From the Melanoma Antigen Tyrosinase.
  Riley, J.P., Rosenberg, S.A., Parkhurst, M.R.> ;J Immunother (1991). 2001 May
• Identification of a new shared HLA-A2.1 restricted epitope from the melanoma antigen tyrosinase.
  Riley JP, Rosenberg SA, Parkhurst MR> ;J. Immunother.. 2001-01-01
• Stimulation of tumor-reactive T lymphocytes using mixtures of synthetic peptides derived from tumor-associated antigens with diverse MHC binding affinities.
  Riley, J. P., Rosenberg, S. A., Parkhurst, M. R.> ;J Immunol Methods. 2003 May 1
• Join now to see all